Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harvard Bioscience (HBIO) Inventory (2016 - 2025)

Historic Inventory for Harvard Bioscience (HBIO) over the last 17 years, with Q3 2025 value amounting to $21.6 million.

  • Harvard Bioscience's Inventory fell 1687.57% to $21.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.6 million, marking a year-over-year decrease of 1687.57%. This contributed to the annual value of $23.2 million for FY2024, which is 595.16% down from last year.
  • Harvard Bioscience's Inventory amounted to $21.6 million in Q3 2025, which was down 1687.57% from $22.3 million recorded in Q2 2025.
  • Over the past 5 years, Harvard Bioscience's Inventory peaked at $29.3 million during Q2 2022, and registered a low of $21.6 million during Q3 2025.
  • In the last 5 years, Harvard Bioscience's Inventory had a median value of $25.8 million in 2023 and averaged $25.3 million.
  • Per our database at Business Quant, Harvard Bioscience's Inventory surged by 2661.4% in 2022 and then crashed by 1687.57% in 2025.
  • Harvard Bioscience's Inventory (Quarter) stood at $27.6 million in 2021, then dropped by 4.16% to $26.4 million in 2022, then fell by 6.52% to $24.7 million in 2023, then dropped by 5.95% to $23.2 million in 2024, then dropped by 7.06% to $21.6 million in 2025.
  • Its last three reported values are $21.6 million in Q3 2025, $22.3 million for Q2 2025, and $22.8 million during Q1 2025.